TreeWAS – Variant ID: rs589636

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
F41.2 Mixed anxiety and depressive disorder	0.000	0.959	0.041
G40.2 Localisation-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures	0.000	0.974	0.026
G40 Epilepsy	0.000	0.974	0.026
G40.1 Localisation-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures	0.000	0.975	0.025
G40.3 Generalised idiopathic epilepsy and epileptic syndromes	0.000	0.976	0.024
G40.6 Grand mal seizures, unspecified (with or without petit mal)	0.000	0.977	0.023
G40.5 Special epileptic syndromes	0.000	0.978	0.022
G40.4 Other generalised epilepsy and epileptic syndromes	0.000	0.981	0.019
G40.7 Petit mal, unspecified, without grand mal seizures	0.000	0.981	0.018
G40.0 Localisation-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localised onset	0.000	0.982	0.018
D25.9 Leiomyoma of uterus, unspecified	0.018	0.982	0.000
Y83.6 Removal of other organ (partial) (total)	0.017	0.983	0.000
G40.8 Other epilepsy	0.000	0.985	0.015
G40.9 Epilepsy, unspecified	0.000	0.986	0.014
M72.04 Palmar fascial fibromatosis [Dupuytren]-Hand	0.000	0.986	0.014
D25.0 Submucous leiomyoma of uterus	0.013	0.987	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.012	0.988	0.000
D25 Leiomyoma of uterus	0.012	0.988	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.011	0.989	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.011	0.989	0.000
T46.1 Calcium-channel blockers	0.010	0.990	0.000
M72.0 Palmar fascial fibromatosis [Dupuytren]	0.000	0.990	0.010
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.009	0.991	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.009	0.991	0.000
J39.8 Other specified diseases of upper respiratory tract	0.009	0.991	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.008	0.992	0.000
T43.2 Other and unspecified antidepressants	0.008	0.992	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.008	0.992	0.000
T46.7 Peripheral vasodilators	0.008	0.992	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.008	0.992	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.008	0.992	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.008	0.992	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.008	0.992	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.008	0.992	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.008	0.992	0.000
M72.09 Palmar fascial fibromatosis [Dupuytren]-Site unspec	0.000	0.992	0.008
T43.3 Phenothiazine antipsychotics and neuroleptics	0.008	0.992	0.000
M72.00 Palmar fascial fibromatosis [Dupuytren]-Mult sites	0.000	0.992	0.008
T46.3 Coronary vasodilators, not elsewhere classified	0.007	0.993	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.007	0.993	0.000
M72.08 Palmar fascial fibromatosis [Dupuytren]-Other	0.000	0.993	0.007
M72.06 Palmar fascial fibromatosis [Dupuytren]-Lower Leg	0.000	0.993	0.007
M72.05 Palmar fascial fibromatosis [Dupuytren]-Pelvic/Thigh	0.000	0.993	0.007
M72.03 Palmar fascial fibromatosis [Dupuytren]-Forearm	0.000	0.993	0.007
M72.02 Palmar fascial fibromatosis [Dupuytren]-Upper arm	0.000	0.993	0.007
M72.01 Palmar fascial fibromatosis [Dupuytren]-Shldr region	0.000	0.993	0.007
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.007	0.993	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.007	0.993	0.000
T43.9 Psychotropic drug, unspecified	0.007	0.993	0.000
M72.07 Palmar fascial fibromatosis [Dupuytren]-Ankle/Foot	0.000	0.993	0.007
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.007	0.993	0.000
T47.0 Histamine H(2)-receptor antagonists	0.007	0.993	0.000
T43.6 Psychostimulants with abuse potential	0.007	0.993	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.007	0.993	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.007	0.993	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.007	0.993	0.000
T36 Poisoning by systemic antibiotics	0.007	0.993	0.000
T47.2 Stimulant laxatives	0.006	0.993	0.000
F41 Other anxiety disorders	0.000	0.993	0.007
T41 Poisoning by anaesthetics and therapeutic gases	0.006	0.994	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.006	0.994	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.006	0.994	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.006	0.994	0.000
T47.7 Emetics	0.006	0.994	0.000
T47.5 Digestants	0.006	0.994	0.000
T47.3 Saline and osmotic laxatives	0.006	0.994	0.000
J39 Other diseases of upper respiratory tract	0.006	0.994	0.000
D86.0 Sarcoidosis of lung	0.000	0.994	0.006
T39.0 Salicylates	0.006	0.994	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.006	0.994	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.006	0.994	0.000
T47.4 Other laxatives	0.006	0.994	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.006	0.994	0.000
T38.1 Thyroid hormones and substitutes	0.006	0.994	0.000
D25.2 Subserosal leiomyoma of uterus	0.006	0.994	0.000
J39.2 Other diseases of pharynx	0.006	0.994	0.000
T47.6 Antidiarrhoeal drugs	0.006	0.994	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.006	0.994	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.006	0.994	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.006	0.994	0.000
M72 Fibroblastic disorders	0.000	0.994	0.006
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.005	0.994	0.000
T38.0 Glucocorticoids and synthetic analogues	0.005	0.994	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.005	0.995	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.005	0.995	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.005	0.995	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.005	0.995	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.005	0.995	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.005	0.995	0.000
T44.0 Anticholinesterase agents	0.005	0.995	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.005	0.995	0.000
T48.4 Expectorants	0.005	0.995	0.000
T48.3 Antitussives	0.005	0.995	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.005	0.995	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.005	0.995	0.000
T48.0 Oxytocic drugs	0.005	0.995	0.000
T36.8 Other systemic antibiotics	0.005	0.995	0.000
T36.3 Macrolides	0.005	0.995	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.005	0.995	0.000
T48.5 Anti-common-cold drugs	0.005	0.995	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.005	0.995	0.000
H02.1 Ectropion of eyelid	0.005	0.995	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.005	0.995	0.000
F41.8 Other specified anxiety disorders	0.000	0.995	0.005
D86 Sarcoidosis	0.000	0.995	0.005
T38.9 Other and unspecified hormone antagonists	0.005	0.995	0.000
T38.7 Androgens and anabolic congeners	0.005	0.995	0.000
T38.4 Oral contraceptives	0.005	0.995	0.000
T38.2 Antithyroid drugs	0.005	0.995	0.000
D86.9 Sarcoidosis, unspecified	0.000	0.995	0.005
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.005	0.995	0.000
J39.0 Retropharyngeal and parapharyngeal abscess	0.005	0.995	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.005	0.995	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.005	0.995	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.005	0.995	0.000
T45.5 Anticoagulants	0.005	0.995	0.000
O80.9 Single spontaneous delivery, unspecified	0.005	0.995	0.000
T38.5 Other oestrogens and progestogens	0.005	0.995	0.000
T36.9 Systemic antibiotic, unspecified	0.005	0.995	0.000
T36.7 Antifungal antibiotics, systemically used	0.005	0.995	0.000
T36.6 Rifamycins	0.005	0.995	0.000
T36.5 Aminoglycosides	0.005	0.995	0.000
T36.2 Chloramphenicol group	0.005	0.995	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.005	0.995	0.000
T37.5 Antiviral drugs	0.005	0.995	0.000
T37.4 Anthelminthics	0.005	0.995	0.000
T37.3 Other antiprotozoal drugs	0.005	0.995	0.000
T37.1 Antimycobacterial drugs	0.005	0.995	0.000
T37.0 Sulphonamides	0.005	0.995	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.005	0.995	0.000
T36.4 Tetracyclines	0.005	0.995	0.000
J39.9 Disease of upper respiratory tract, unspecified	0.005	0.995	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.005	0.995	0.000
T41.5 Therapeutic gases	0.005	0.995	0.000
T41.4 Anaesthetic, unspecified	0.005	0.995	0.000
T41.3 Local anaesthetics	0.005	0.995	0.000
T41.1 Intravenous anaesthetics	0.005	0.995	0.000
T41.0 Inhaled anaesthetics	0.005	0.995	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.005	0.995	0.000
F41.3 Other mixed anxiety disorders	0.000	0.995	0.005
T39.4 Antirheumatics, not elsewhere classified	0.005	0.995	0.000
T39.2 Pyrazolone derivatives	0.005	0.995	0.000
D86.1 Sarcoidosis of lymph nodes	0.000	0.995	0.005
J39.3 Upper respiratory tract hypersensitivity reaction, site unspecified	0.005	0.995	0.000
J39.1 Other abscess of pharynx	0.005	0.995	0.000
M72.2 Plantar fascial fibromatosis	0.000	0.995	0.005
T50.7 Analeptics and opioid receptor antagonists	0.005	0.995	0.000
T50.5 Appetite depressants	0.005	0.995	0.000
T50.4 Drugs affecting uric acid metabolism	0.005	0.995	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.005	0.995	0.000
T50.0 Mineralocorticoids and their antagonists	0.005	0.995	0.000
T41.2 Other and unspecified general anaesthetics	0.004	0.995	0.000
T49.9 Topical agent, unspecified	0.004	0.995	0.000
T49.8 Other topical agents	0.004	0.995	0.000
T49.7 Dental drugs, topically applied	0.004	0.995	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.004	0.995	0.000
T49.5 Ophthalmological drugs and preparations	0.004	0.995	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.004	0.995	0.000
T49.3 Emollients, demulcents and protectants	0.004	0.995	0.000
T49.2 Local astringents and local detergents	0.004	0.995	0.000
T49.1 Antipruritics	0.004	0.995	0.000
T45.2 Vitamins, not elsewhere classified	0.004	0.995	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.005	0.995	0.000
M72.9 Fibroblastic disorder, unspecified	0.000	0.995	0.004
M72.1 Knuckle pads	0.000	0.995	0.004
T50.1 Loop [high-ceiling] diuretics	0.004	0.995	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.004	0.995	0.000
T45.8 Other primarily systemic and haematological agents	0.004	0.995	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.004	0.995	0.000
T45.6 Fibrinolysis-affecting drugs	0.004	0.995	0.000
T45.3 Enzymes, not elsewhere classified	0.004	0.995	0.000
T45.4 Iron and its compounds	0.004	0.995	0.000
M72.5 Fasciitis, not elsewhere classified	0.000	0.996	0.004
D86.8 Sarcoidosis of other and combined sites	0.000	0.996	0.004
D25.1 Intramural leiomyoma of uterus	0.004	0.996	0.000
M72.8 Other fibroblastic disorders	0.000	0.996	0.004
M72.4 Pseudosarcomatous fibromatosis	0.000	0.996	0.004
M72.3 Nodular fasciitis	0.000	0.996	0.004
T50.8 Diagnostic agents	0.004	0.996	0.000
M72.6 Necrotizing fasciitis	0.000	0.996	0.004
M67.2 Synovial hypertrophy, not elsewhere classified	0.000	0.996	0.004
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.004	0.996	0.000
T40.6 Other and unspecified narcotics	0.004	0.996	0.000
T42.0 Hydantoin derivatives	0.004	0.996	0.000
T40.1 Heroin	0.004	0.996	0.000
T42.1 Iminostilbenes	0.004	0.996	0.000
M72.29 Plantar fascial fibromatosis-Site unspec	0.000	0.996	0.004
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.004	0.996	0.000
T42.3 Barbiturates	0.004	0.996	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.004	0.996	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.004	0.996	0.000
T40.8 Lysergide [LSD]	0.004	0.996	0.000
T40.7 Cannabis (derivatives)	0.004	0.996	0.000
T40.0 Opium	0.004	0.996	0.000
T36.0 Penicillins	0.004	0.996	0.000
T40.5 Cocaine	0.004	0.996	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.004	0.996	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.004	0.996	0.000
T42.2 Succinimides and oxazolidinediones	0.004	0.996	0.000
T40.3 Methadone	0.004	0.996	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.004	0.996	0.000
D86.2 Sarcoidosis of lung with sarcoidosis of lymph nodes	0.000	0.996	0.004
D86.3 Sarcoidosis of skin	0.000	0.996	0.004
M72.14 Knuckle pads (Hand)	0.000	0.996	0.004
M72.94 Fibroblastic disorder, unspecified (Hand)	0.000	0.996	0.004
M72.28 Plantar fascial fibromatosis-Other	0.000	0.996	0.003
M72.26 Plantar fascial fibromatosis-Lower Leg	0.000	0.996	0.003
M72.25 Plantar fascial fibromatosis-Pelvic/Thigh	0.000	0.996	0.003
M72.24 Plantar fascial fibromatosis-Hand	0.000	0.996	0.003
M72.23 Plantar fascial fibromatosis-Forearm	0.000	0.996	0.003
M72.22 Plantar fascial fibromatosis-Upper arm	0.000	0.996	0.003
M72.21 Plantar fascial fibromatosis-Shldr region	0.000	0.996	0.003
M72.20 Plantar fascial fibromatosis-Mult sites	0.000	0.996	0.003
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.004	0.996	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.003	0.996	0.000
M72.27 Plantar fascial fibromatosis-Ankle/Foot	0.000	0.996	0.004
T39.1 4-Aminophenol derivatives	0.004	0.996	0.000
M67.8 Other specified disorders of synovium and tendon	0.000	0.996	0.004
O36.0 Maternal care for rhesus isoimmunisation	0.004	0.996	0.000
T45.0 Antiallergic and antiemetic drugs	0.003	0.996	0.000
M72.58 Fasciitis, not elsewhere classified-Other	0.000	0.996	0.003
S02.00 Fracture of vault of skull (closed)	0.000	0.996	0.004
M72.99 Fibroblastic disorder, unspecified (Site unspecified)	0.000	0.996	0.003
M72.98 Fibroblastic disorder, unspecified (Other)	0.000	0.996	0.003
M72.97 Fibroblastic disorder, unspecified (Ankle and foot)	0.000	0.996	0.003
M72.96 Fibroblastic disorder, unspecified (Lower leg)	0.000	0.996	0.003
M72.95 Fibroblastic disorder, unspecified (Pelvic region and thigh)	0.000	0.996	0.003
M72.93 Fibroblastic disorder, unspecified (Forearm)	0.000	0.996	0.003
M72.92 Fibroblastic disorder, unspecified (Upper arm)	0.000	0.996	0.003
M72.91 Fibroblastic disorder, unspecified (Shoulder region)	0.000	0.996	0.003
M72.90 Fibroblastic disorder, unspecified (Multiple sites)	0.000	0.996	0.003
M72.19 Knuckle pads (Site unspecified)	0.000	0.996	0.003
M72.18 Knuckle pads-Other	0.000	0.996	0.003
M72.17 Knuckle pads (Ankle and foot)	0.000	0.996	0.003
M72.16 Knuckle pads-Lower Leg	0.000	0.996	0.003
M72.15 Knuckle pads-Pelvic/Thigh	0.000	0.996	0.003
M72.13 Knuckle pads-Forearm	0.000	0.996	0.003
M72.12 Knuckle pads-Upper arm	0.000	0.996	0.003
M72.11 Knuckle pads-Shldr region	0.000	0.996	0.003
M72.10 Knuckle pads (Multiple sites)	0.000	0.996	0.003
T40.4 Other synthetic narcotics	0.003	0.996	0.000
M72.59 Fasciitis, not elsewhere classified-Site unspec	0.000	0.997	0.003
M72.57 Fasciitis, not elsewhere classified-Ankle/Foot	0.000	0.997	0.003
M72.56 Fasciitis, not elsewhere classified-Lower Leg	0.000	0.997	0.003
M72.54 Fasciitis, not elsewhere classified-Hand	0.000	0.997	0.003
M72.53 Fasciitis, not elsewhere classified-Forearm	0.000	0.997	0.003
M72.52 Fasciitis, not elsewhere classified-Upper arm	0.000	0.997	0.003
M72.51 Fasciitis, not elsewhere classified-Shldr region	0.000	0.997	0.003
M72.50 Fasciitis, not elsewhere classified-Mult sites	0.000	0.997	0.003
S82.50 Fracture of medial malleolus (closed)	0.000	0.997	0.003
F41.1 Generalised anxiety disorder	0.000	0.997	0.003
M72.55 Fasciitis, not elsewhere classified-Pelvic/Thigh	0.000	0.997	0.003
M72.39 Nodular fasciitis-Site unspec	0.000	0.997	0.003
M72.38 Nodular fasciitis-Other	0.000	0.997	0.003
M72.37 Nodular fasciitis-Ankle/Foot	0.000	0.997	0.003
M72.36 Nodular fasciitis-Lower Leg	0.000	0.997	0.003
M72.35 Nodular fasciitis-Pelvic/Thigh	0.000	0.997	0.003
M72.34 Nodular fasciitis-Hand	0.000	0.997	0.003
M72.33 Nodular fasciitis-Forearm	0.000	0.997	0.003
M72.32 Nodular fasciitis-Upper arm	0.000	0.997	0.003
M72.31 Nodular fasciitis-Shldr region	0.000	0.997	0.003
M72.30 Nodular fasciitis-Mult sites	0.000	0.997	0.003
M72.49 Pseudosarcomatous fibromatosis (Site unspecified)	0.000	0.997	0.003
M72.48 Pseudosarcomatous fibromatosis (Other)	0.000	0.997	0.003
M72.47 Pseudosarcomatous fibromatosis (Ankle and foot)	0.000	0.997	0.003
M72.46 Pseudosarcomatous fibromatosis (Lower leg)	0.000	0.997	0.003
M72.45 Pseudosarcomatous fibromatosis (Pelvic region and thigh)	0.000	0.997	0.003
M72.44 Pseudosarcomatous fibromatosis (Hand)	0.000	0.997	0.003
M72.43 Pseudosarcomatous fibromatosis (Forearm)	0.000	0.997	0.003
M72.42 Pseudosarcomatous fibromatosis (Upper arm)	0.000	0.997	0.003
M72.41 Pseudosarcomatous fibromatosis (Shoulder region)	0.000	0.997	0.003
M72.40 Pseudosarcomatous fibromatosis (Multiple sites)	0.000	0.997	0.003
M72.89 Other fibroblastic disorders (Site unspecified)	0.000	0.997	0.003
M72.88 Other fibroblastic disorders (Other)	0.000	0.997	0.003
M72.87 Other fibroblastic disorders (Ankle and foot)	0.000	0.997	0.003
M72.86 Other fibroblastic disorders (Lower leg)	0.000	0.997	0.003
M72.85 Other fibroblastic disorders (Pelvic region and thigh)	0.000	0.997	0.003
M72.84 Other fibroblastic disorders (Hand)	0.000	0.997	0.003
M72.83 Other fibroblastic disorders (Forearm)	0.000	0.997	0.003
M72.82 Other fibroblastic disorders (Upper arm)	0.000	0.997	0.003
M72.81 Other fibroblastic disorders (Shoulder region)	0.000	0.997	0.003
M72.80 Other fibroblastic disorders (Multiple sites)	0.000	0.997	0.003
T43.0 Tricyclic and tetracyclic antidepressants	0.003	0.997	0.000
M72.69 Necrotizing fasciitis (Site unspecified)	0.000	0.997	0.003
M72.67 Necrotizing fasciitis (Ankle and foot)	0.000	0.997	0.003
M72.66 Necrotizing fasciitis (Lower leg)	0.000	0.997	0.003
M72.65 Necrotizing fasciitis (Pelvic region and thigh)	0.000	0.997	0.003
M72.64 Necrotizing fasciitis (Hand)	0.000	0.997	0.003
M72.63 Necrotizing fasciitis (Forearm)	0.000	0.997	0.003
M72.62 Necrotizing fasciitis (Upper arm)	0.000	0.997	0.003
M72.61 Necrotizing fasciitis (Shoulder region)	0.000	0.997	0.003
M72.60 Necrotizing fasciitis (Multiple sites)	0.000	0.997	0.003
M72.68 Necrotizing fasciitis (Other)	0.000	0.997	0.003
F41.9 Anxiety disorder, unspecified	0.000	0.997	0.003
F41.0 Panic disorder [episodic paroxysmal anxiety]	0.000	0.997	0.003
I51.8 Other ill-defined heart diseases	0.000	0.997	0.003
M67 Other disorders of synovium and tendon	0.000	0.997	0.003
M23.81 Other internal derangements of knee (Anterior cruciate ligament or Anterior horn of medial meniscus)	0.000	0.997	0.003
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.002	0.997	0.001
Y40.9 Systemic antibiotic, unspecified	0.003	0.997	0.000
F33.2 Recurrent depressive disorder, current episode severe without psychotic symptoms	0.003	0.997	0.000
T40.2 Other opioids	0.003	0.997	0.000
M67.1 Other contracture of tendon (sheath)	0.000	0.997	0.003
M67.9 Disorder of synovium and tendon, unspecified	0.000	0.997	0.002
M67.3 Transient synovitis	0.000	0.997	0.002
M23.8 Other internal derangements of knee	0.000	0.997	0.002
K86.8 Other specified diseases of pancreas	0.000	0.998	0.002
M23.89 Other internal derangements of knee (Unspecified ligament or Unspecified meniscus)	0.000	0.998	0.002
M23.83 Other internal derangements of knee (Medial collateral ligament or Other and unspecified medial meniscus)	0.000	0.998	0.002
M79.65 Pain in limb (Pelvic region and thigh)	0.002	0.998	0.000
D63.0 Anaemia in neoplastic disease	0.000	0.998	0.002
R40.2 Coma, unspecified	0.000	0.998	0.002
M67.0 Short Achilles tendon (acquired)	0.000	0.998	0.002
O80 Single spontaneous delivery	0.002	0.998	0.000
H73.8 Other specified disorders of tympanic membrane	0.002	0.998	0.000
K00.6 Disturbances in tooth eruption	0.002	0.998	0.000
M23.87 Other internal derangements of knee (Capsular ligament)	0.000	0.998	0.002
M35.0 Sicca syndrome [Sjogren]	0.002	0.998	0.000
M23.86 Other internal derangements of knee (Other and unspecified lateral meniscus)	0.000	0.998	0.002
M67.4 Ganglion	0.000	0.998	0.002
M23.80 Other internal derangements of knee (Multiple sites)	0.000	0.998	0.002
M67.96 Unspecified disorder of synovium and tendon, lower leg	0.000	0.998	0.002
N95.2 Postmenopausal atrophic vaginitis	0.000	0.998	0.002
M23.85 Other internal derangements of knee (Posterior horn of lateral meniscus)	0.000	0.998	0.002
F33.0 Recurrent depressive disorder, current episode mild	0.002	0.998	0.000
F33.1 Recurrent depressive disorder, current episode moderate	0.002	0.998	0.000
H81.0 Meniere's disease	0.002	0.998	0.000
F33 Recurrent depressive disorder	0.002	0.998	0.000
R46.8 Other symptoms and signs involving appearance and behaviour	0.002	0.998	0.000
K29.0 Acute haemorrhagic gastritis	0.002	0.998	0.000
L30.9 Dermatitis, unspecified	0.002	0.998	0.000
M79.63 Pain in limb (Forearm)	0.002	0.998	0.000
M19.04 Primary arthrosis of other joints (Hand)	0.002	0.998	0.000
G47.8 Other sleep disorders	0.000	0.998	0.002
O80.1 Spontaneous breech delivery	0.002	0.998	0.000
S02.0 Fracture of vault of skull	0.000	0.998	0.002
O80.8 Other single spontaneous delivery	0.002	0.998	0.000
M23.84 Other internal derangements of knee (Lateral collateral ligament or Anterior horn of lateral meniscus)	0.000	0.998	0.002
M23.82 Other internal derangements of knee (Posterior cruciate ligament or Posterior horn of medial meniscus)	0.000	0.998	0.002
H54.9 Unspecified visual impairment (binocular)	0.000	0.998	0.002
I47.9 Paroxysmal tachycardia, unspecified	0.002	0.998	0.000
S72.40 Fracture of lower end of femur (closed)	0.002	0.998	0.000
K25.3 Acute without haemorrhage or perforation	0.002	0.998	0.000
M67.49 Ganglion, multiple sites	0.000	0.998	0.002
M67.45 Ganglion, hip	0.000	0.998	0.002
S82.30 Fracture of lower end of tibia (closed)	0.002	0.998	0.000
F05.9 Delirium, unspecified	0.002	0.998	0.000
S02.01 Fracture of vault of skull (open)	0.000	0.998	0.002
S72.20 Subtrochanteric fracture (closed)	0.002	0.998	0.000
F33.3 Recurrent depressive disorder, current episode severe with psychotic symptoms	0.002	0.998	0.000
H73.9 Disorder of tympanic membrane, unspecified	0.002	0.998	0.000
T88.6 Anaphylactic shock due to adverse effect of correct drug or medicament properly administered	0.002	0.998	0.000
D80-D89 Certain disorders involving the immune mechanism	0.000	0.998	0.002
B97.7 Papillomavirus as the cause of diseases classified to other chapters	0.002	0.998	0.000
D63.8 Anaemia in other chronic diseases classified elsewhere	0.000	0.998	0.002
H73 Other disorders of tympanic membrane	0.002	0.998	0.000
H53.2 Diplopia	0.000	0.998	0.002
H73.1 Chronic myringitis	0.002	0.998	0.000
S72.10 Pertrochanteric fracture (closed)	0.002	0.998	0.000
M67.43 Ganglion, wrist	0.000	0.998	0.001
D84 Other immunodeficiencies	0.000	0.998	0.002
F52.2 Failure of genital response	0.002	0.998	0.000
L85.9 Epidermal thickening, unspecified	0.000	0.998	0.002
N05.9 Unspecified	0.002	0.998	0.000
O80.0 Spontaneous vertex delivery	0.002	0.998	0.000
D84.9 Immunodeficiency, unspecified	0.000	0.998	0.002
F32.3 Severe depressive episode with psychotic symptoms	0.002	0.998	0.000
D63 Anaemia in chronic diseases classified elsewhere	0.000	0.998	0.002
B95.6 Staphylococcus aureus as the cause of diseases classified to other chapters	0.002	0.998	0.000
K80.4 Calculus of bile duct with cholecystitis	0.002	0.998	0.000
F33.4 Recurrent depressive disorder, currently in remission	0.001	0.998	0.000
M67.47 Ganglion, ankle and foot	0.000	0.998	0.001
F33.9 Recurrent depressive disorder, unspecified	0.002	0.998	0.000
F33.8 Other recurrent depressive disorders	0.001	0.998	0.000
H54.7 Unspecified visual loss	0.000	0.998	0.002
D82 Immunodeficiency associated with other major defects	0.000	0.998	0.001
D84.1 Defects in the complement system	0.000	0.998	0.001
A40.0 Septicaemia due to streptococcus, group A	0.000	0.998	0.002
S41.1 Open wound of upper arm	0.000	0.998	0.002
H54 Blindness and low vision	0.000	0.998	0.002
H90.4 Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side	0.000	0.998	0.002
S61.0 Open wound of finger(s) without damage to nail	0.000	0.998	0.002
D81 Combined immunodeficiencies	0.000	0.998	0.001
M21.37 Wrist or foot drop (acquired) (Ankle and foot)	0.001	0.998	0.000
S82.5 Fracture of medial malleolus	0.000	0.998	0.001
U80.0 Penicillin resistant agent	0.001	0.998	0.000
V18.0 Driver injured in nontraffic accident	0.000	0.998	0.002
D82.1 Di George's syndrome	0.000	0.998	0.001
D84.0 Lymphocyte function antigen-1 [LFA-1] defect	0.000	0.998	0.001
H73.0 Acute myringitis	0.001	0.998	0.000
I33.0 Acute and subacute infective endocarditis	0.001	0.998	0.000
L98.8 Other specified disorders of skin and subcutaneous tissue	0.002	0.998	0.000
M79.62 Pain in limb (Upper arm)	0.001	0.999	0.000
E10.3 With ophthalmic complications	0.000	0.999	0.001
S72.4 Fracture of lower end of femur	0.001	0.999	0.000
S72.2 Subtrochanteric fracture	0.001	0.999	0.000
D63.1 Anaemia in other chronic diseases classified elsewhere	0.000	0.999	0.001
H54.5 Low vision, one eye	0.000	0.999	0.001
O99.6 Diseases of the digestive system complicating pregnancy, childbirth and the puerperium	0.000	0.999	0.001
D83 Common variable immunodeficiency	0.000	0.999	0.001
L73.2 Hidradenitis suppurativa	0.001	0.999	0.000
D69.6 Thrombocytopenia, unspecified	0.001	0.999	0.000
S72.1 Pertrochanteric fracture	0.001	0.999	0.000
Y40.0 Penicillins	0.001	0.999	0.000
Y40 Systemic antibiotics	0.001	0.999	0.000
D82.9 Immunodeficiency associated with major defect, unspecified	0.000	0.999	0.001
D82.8 Immunodeficiency associated with other specified major defects	0.000	0.999	0.001
D82.4 Hyperimmunoglobulin E [IgE] syndrome	0.000	0.999	0.001
D82.2 Immunodeficiency with short-limbed stature	0.000	0.999	0.001
D82.0 Wiskott-Aldrich syndrome	0.000	0.999	0.001
D84.8 Other specified immunodeficiencies	0.000	0.999	0.001
H53.1 Subjective visual disturbances	0.000	0.999	0.001
Y40.8 Other systemic antibiotics	0.001	0.999	0.000
D82.3 Immunodeficiency following hereditary defective response to Epstein-Barr virus	0.000	0.999	0.001
H54.0 Blindness, both eyes	0.000	0.999	0.001
A40.1 Septicaemia due to streptococcus, group B	0.000	0.999	0.001
H54.6 Unqualified visual loss, one eye	0.000	0.999	0.001
H54.3 Unqualified visual loss, both eyes	0.000	0.999	0.001
H54.1 Blindness, one eye, low vision, other eye	0.000	0.999	0.001
N94.1 Dyspareunia	0.001	0.999	0.000
O99.2 Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium	0.000	0.999	0.001
Z43.2 Attention to ileostomy	0.001	0.999	0.000
D81.9 Combined immunodeficiency, unspecified	0.000	0.999	0.001
D81.8 Other combined immunodeficiencies	0.000	0.999	0.001
D81.7 Major histocompatibility complex class II deficiency	0.000	0.999	0.001
D81.6 Major histocompatibility complex class I deficiency	0.000	0.999	0.001
D81.5 Purine nucleoside phosphorylase [PNP] deficiency	0.000	0.999	0.001
D81.4 Nezelof's syndrome	0.000	0.999	0.001
D81.3 Adenosine deaminase [ADA] deficiency	0.000	0.999	0.001
D81.2 Severe combined immunodeficiency [SCID] with low or normal B-cell numbers	0.000	0.999	0.001
D81.1 Severe combined immunodeficiency [SCID] with low T- and B-cell numbers	0.000	0.999	0.001
D81.0 Severe combined immunodeficiency [SCID] with reticular dysgenesis	0.000	0.999	0.001
H54.2 Low vision, both eyes	0.000	0.999	0.001
K00.9 Disorder of tooth development, unspecified	0.001	0.999	0.000
R46.2 Strange and inexplicable behaviour	0.001	0.999	0.000
K00 Disorders of tooth development and eruption	0.001	0.999	0.000
S72.21 Subtrochanteric fracture (open)	0.001	0.999	0.000
H04.2 Epiphora	0.001	0.999	0.000
H53.4 Visual field defects	0.000	0.999	0.001
D83.8 Other common variable immunodeficiencies	0.000	0.999	0.001
D83.2 Common variable immunodeficiency with autoantibodies to B- or T-cells	0.000	0.999	0.001
D83.1 Common variable immunodeficiency with predominant immunoregulatory T-cell disorders	0.000	0.999	0.001
D83.0 Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function	0.000	0.999	0.001
K00.1 Supernumerary teeth	0.001	0.999	0.000
Z88.9 Personal history of allergy to unspecified drugs, medicaments and biological substances	0.001	0.999	0.000
S72.11 Pertrochanteric fracture (open)	0.001	0.999	0.000
S72.41 Fracture of lower end of femur (open)	0.001	0.999	0.000
S82.51 Fracture of medial malleolus (open)	0.000	0.999	0.001
E87.3 Alkalosis	0.000	0.999	0.001
G11.9 Hereditary ataxia, unspecified	0.001	0.999	0.000
Y40.7 Antifungal antibiotics, systemically used	0.001	0.999	0.000
I51.4 Myocarditis, unspecified	0.000	0.999	0.001
R84.5 Abnormal microbiological findings	0.001	0.999	0.000
Y40.6 Rifamycins	0.001	0.999	0.000
Y40.4 Tetracyclines	0.001	0.999	0.000
Y40.2 Chloramphenicol group	0.001	0.999	0.000
K00.0 Anodontia	0.001	0.999	0.000
D83.9 Common variable immunodeficiency, unspecified	0.000	0.999	0.001
C55 Malignant neoplasm of uterus, part unspecified	0.001	0.999	0.000
K00.7 Teething syndrome	0.001	0.999	0.000
K00.5 Hereditary disturbances in tooth structure, not elsewhere classified	0.001	0.999	0.000
K00.4 Disturbances in tooth formation	0.001	0.999	0.000
K00.3 Mottled teeth	0.001	0.999	0.000
K00.2 Abnormalities of size and form of teeth	0.001	0.999	0.000
R52.0 Acute pain	0.001	0.999	0.000
D80 Immunodeficiency with predominantly antibody defects	0.000	0.999	0.001
C67.6 Ureteric orifice	0.000	0.999	0.001
E07.8 Other specified disorders of thyroid	0.001	0.999	0.000
I80.2 Phlebitis and thrombophlebitis of other deep vessels of lower extremities	0.000	0.999	0.001
O99.7 Diseases of the skin and subcutaneous tissue complicating pregnancy, childbirth and the puerperium	0.000	0.999	0.001
I08.1 Disorders of both mitral and tricuspid valves	0.001	0.999	0.000
K14.0 Glossitis	0.001	0.999	0.000
Y40.3 Macrolides	0.001	0.999	0.000
S72.31 Fracture of shaft of femur (open)	0.001	0.999	0.000
K00.8 Other disorders of tooth development	0.001	0.999	0.000
O99.5 Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium	0.000	0.999	0.001
S72.3 Fracture of shaft of femur	0.001	0.999	0.000
M21.57 Acquired clawhand, clubhand, clawfoot and clubfoot (Ankle and foot)	0.000	0.999	0.001
M89.97 Disorder of bone, unspecified (Ankle and foot)	0.001	0.999	0.000
D80.4 Selective deficiency of immunoglobulin M [IgM]	0.000	0.999	0.001
H10.9 Conjunctivitis, unspecified	0.001	0.999	0.000
Z30.1 Insertion of (intra-uterine) contraceptive device	0.000	0.999	0.001
R46 Symptoms and signs involving appearance and behaviour	0.001	0.999	0.000
S72 Fracture of femur	0.001	0.999	0.000
D80.7 Transient hypogammaglobulinaemia of infancy	0.000	0.999	0.001
D80.6 Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia	0.000	0.999	0.001
D80.5 Immunodeficiency with increased immunoglobulin M [IgM]	0.000	0.999	0.001
D80.0 Hereditary hypogammaglobulinaemia	0.000	0.999	0.001
G57.8 Other mononeuropathies of lower limb	0.001	0.999	0.000
H54.4 Blindness, one eye	0.000	0.999	0.001
I60.1 Subarachnoid haemorrhage from middle cerebral artery	0.001	0.999	0.000
T90.9 Sequelae of unspecified injury of head	0.000	0.999	0.001
Y40.5 Aminoglycosides	0.001	0.999	0.000
S72.30 Fracture of shaft of femur (closed)	0.001	0.999	0.000
D40.0 Prostate	0.001	0.999	0.000
H74.4 Polyp of middle ear	0.001	0.999	0.000
V18.2 Unspecified pedal cyclist injured in nontraffic accident	0.000	0.999	0.001
M46.96 Inflammatory spondylopathy, unspecified (Lumbar region)	0.000	0.999	0.001
D06.9 Cervix, unspecified	0.001	0.999	0.000
D80.2 Selective deficiency of immunoglobulin A [IgA]	0.000	0.999	0.001

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations